CompletedNot Applicable

Renal Replacement Therapy and In-Hospital Mortality Incidence in Cardiac Surgery Associated Acute Kidney Injury

Indonesia1,113 participantsStarted 2023-10-01

Plain-language summary

The goal of this study is to analyse the relation of severe acute kidney injury post cardiac surgery which characterised by the need of renal replacement therapy, with in-hospital postoperative mortality incidence. The main question it aims to answer: To compare between patients complicated with acute kidney injury and exposure of renal replacement therapy (AKI-RRT) and patients complicated with acute kidney injury which does not require renal replacement therapy, in associated with in-hospital postoperative mortality.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients who are at least 18 years old, underwent cardiac surgery in Harapan Kita National Cardiovascular Center from January 2020 to December 2022.
✓. Patients with condition was complicated with Acute Kidney Injury (AKI) which was characterised by an increase in serum creatinine \> 0.3 mg/dL or \> 150% of the preoperative serum creatinine value, which was checked within 12 hours post-operative.
✓. All patients' data is recorded in the medical records unit.

Exclusion criteria

✕. Patients with previous history of dialysis or renal failure in dialysis.
✕. Incomplete or loss of patients' data.

What they're measuring

Mortality

Timeframe: From ICU admission postoperative until the death date during hospital care, assessed up to 3 months

Trial details

NCT IDNCT06091982

SponsorNational Cardiovascular Center Harapan Kita Hospital Indonesia

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-06-30

Results submitted2024-07-08

View on ClinicalTrials.gov More Acute Kidney Injury trials